Trials / Completed
CompletedNCT02304835
Feasibility of a Self-performed Urinary Test for the Follow-up on Medical Abortion
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 322 (actual)
- Sponsor
- Nordic Pharma SAS · Industry
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study was a national, longitudinal, prospective, observational survey, carried out in metropolitan France, with a sampling of 21 birth control centres. The aim of this study was to assess, in real life conditions, the benefit of a urinary semi-quantitative test (hCG Duo 5-1000) in the follow-up of medical abortion by analysing the concordance between qualitative results from the urinary test and quantitative values from the beta-hCG blood measurement.
Conditions
Timeline
- Start date
- 2013-05-01
- Primary completion
- 2013-11-01
- Completion
- 2013-11-01
- First posted
- 2014-12-02
- Last updated
- 2014-12-05
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02304835. Inclusion in this directory is not an endorsement.